Ather Energy raises ₹1,300 crore in QIP for manufacturing and product expansion

Ather Energy has raised ₹1,300 crore through an eight-times oversubscribed qualified institutional placement, issuing 1.08 crore shares at ₹1,202 each. The funding supports manufacturing expansion and product development under its broader ₹2,500-crore capital-infusion plan.

— Source publishedTue, 21 Jul, 2026, 19:36 IST·First seen Tue, 21 Jul, 2026, 19:43 IST·Source The Hindu BusinessLine

What happened

Ather Energy raised ₹1,300 crore through an eight-times oversubscribed QIP to fund manufacturing expansion and product development, as part of its broader

Key facts

  • ₹1,300 crore QIP raise
  • ₹2,500 crore capital infusion plan
  • 1.08 crore equity shares issued
  • ₹1,202 per share
  • QIP oversubscribed 8 times

Why this matters

Ather’s fresh capital improves its strategic flexibility for manufacturing, technology and product investments, potentially raising the competitive bar for EV partners, suppliers and rivals.

What to watch

  • Quarterly electric-scooter registrations and Ather's market-share trend versus Ola Electric, TVS, Bajaj and Hero MotoCorp.
  • Details on new plant capacity, commissioning timelines, utilization rates and capex commitments.
  • New product-launch cadence, especially lower-price or mass-market models.
  • Gross-margin trajectory, EBITDA losses and cash burn following the QIP.
  • Dealer additions, service turnaround times and charging-network expansion.
  • Changes to EV subsidies, battery-safety regulation, import duties or financing availability.
  • Institutional shareholding changes and use-of-proceeds disclosures under the ₹2,500-crore capital-infusion plan.
  • Accelerate manufacturing expansion, automation and supplier capacity commitments.
  • Increase investment in new scooter platforms, battery systems, connected features and charging infrastructure.
  • Expand experience centres, dealer/service footprint and customer-finance partnerships in underpenetrated cities.
  • Use the wider capital-infusion plan to strengthen working capital, inventory availability and after-sales service capacity.
  • Prioritize margin improvement through localization, component sourcing and higher utilization of manufacturing assets.